# Protective Effect of Angong Niuhuang Against Negative Inflammatory Response and Neurologic Dysfunction After Cardiovascular Surgery

> **NCT06723366** · NA · NOT_YET_RECRUITING · sponsor: **Nanjing Medical University** · enrollment: 120 (estimated)

## Conditions studied

- Cardio-pulmonary Bypass
- Cardiovascular Surgery
- Cerebral Protection
- Brain Injury

## Interventions

- **DRUG:** Angong Niuhuang Pill (ANP)
- **OTHER:** Control (Standard treatment)

## Key facts

- **NCT ID:** NCT06723366
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2024-12-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06723366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06723366, "Protective Effect of Angong Niuhuang Against Negative Inflammatory Response and Neurologic Dysfunction After Cardiovascular Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06723366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*